Author | Emma Thomasson

Articles

Novartis Seeks to Buy Rest of Alcon for $39 Billion

January 11, 2010

Novartis, which was widely tipped to snap up Nestle's stake as soon as its option allowed, also aims to buy out the 23 percent held by minority shareholders for $11.2 billion, ending uncertainty over whether or not it would seek full control.

Novartis Seeks to Buy Rest of Alcon for $39 Billion

January 11, 2010

Novartis, which was widely tipped to snap up Nestle's stake as soon as its option allowed, also aims to buy out the 23 percent held by minority shareholders for $11.2 billion, ending uncertainty over whether or not it would seek full control.